Skip to main content

Dr. John Phillips, MD

Medical Genetics (Clinical Genetics (M.D.) Physician)

At a glance

Years since graduation
57
In the NPI registry since
2006

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1969Medical school: Wake Forest University School of Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Clinical Genetics (M.D.) Physician primary
    TN license MD15808
  • Pediatrics Physician
    TN license MD15808

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Medical Genetics per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Industry-funded research

Named as a principal investigator on 4 industry-funded studies in 2025, from 1 companies. The companies reported $148,641 in research payments for these studies, mostly to the institutions running them.

  • A Phase 2 Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia
    BioMarin Pharmaceutical Inc.
  • BMN 165-501
    BioMarin Pharmaceutical Inc.
  • BMN 165-503
    BioMarin Pharmaceutical Inc.
  • A Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of BMN 111 in Children With Achondroplasia
    BioMarin Pharmaceutical Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Medical Genetics clinicians in Nashville

Sources

NPI registry (CMS NPPES, November 2026; record last updated March 30, 2022), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1649362070. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.